On Friday 28th of November Neuro-Bio’s CEO, Susan Greenfield, opens Aptamer Group’s new state-of-the-art laboratories and presented on the challenges in scientific discovery.
To read the full article, click the link.
LATEST NEWS
- Neuro-Bio new publication – A novel 14mer peptide, T14, is associated with age-dependent behaviour in female mice
- Baroness Greenfield attends Club Vita Webinar “The Risk of Living Longer S02 E04: Preventing Dementia”
- Baroness Greenfield’s Interview at La Vanguardia – A Spanish Newspaper, based in Barcelona talking about Alzheimer’s Disease
- Baroness Greenfield’s Presentation at Brain Innovation Days in Brussels – November 2024!
- Neuro-Bio new publication – A Novel 14mer Peptide Inhibits Autophagic Flux via Selective Activation of the mTORC1 Signalling Pathway: Implications for Alzheimer’s Disease